PL383867A1 - Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej - Google Patents

Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej

Info

Publication number
PL383867A1
PL383867A1 PL383867A PL38386707A PL383867A1 PL 383867 A1 PL383867 A1 PL 383867A1 PL 383867 A PL383867 A PL 383867A PL 38386707 A PL38386707 A PL 38386707A PL 383867 A1 PL383867 A1 PL 383867A1
Authority
PL
Poland
Prior art keywords
furfurylocitosin
ageing composition
obtaining
production
manner
Prior art date
Application number
PL383867A
Other languages
English (en)
Other versions
PL216370B1 (pl
Inventor
Jan Barciszewski
Wojciech T. Markiewicz
Eliza Wyszko
Maria Markiewicz
Monika Nowak
Katarzyna Rolle
Ewelina Adamska
Marcin K. Chmielewski
Original Assignee
Instytut Chemii Bioorganicznej Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Chemii Bioorganicznej Pan filed Critical Instytut Chemii Bioorganicznej Pan
Priority to PL383867A priority Critical patent/PL216370B1/pl
Priority to DK08851400.5T priority patent/DK2225228T3/en
Priority to US12/744,349 priority patent/US8404660B2/en
Priority to EP08851400.5A priority patent/EP2225228B1/en
Priority to PCT/PL2008/000089 priority patent/WO2009067035A2/en
Priority to PL08851400T priority patent/PL2225228T3/pl
Priority to ES08851400.5T priority patent/ES2610209T3/es
Publication of PL383867A1 publication Critical patent/PL383867A1/pl
Publication of PL216370B1 publication Critical patent/PL216370B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
PL383867A 2007-11-25 2007-11-25 Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej PL216370B1 (pl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PL383867A PL216370B1 (pl) 2007-11-25 2007-11-25 Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej
DK08851400.5T DK2225228T3 (en) 2007-11-25 2008-11-25 PROCEDURE FOR OBTAINING 4-N-FURFURYLYCTOSIN AND / OR ITS DERIVATIVES, ANTI-AGING COMPOSITION AND USING 4-N-FURFURYLYCTOSIN AND / OR ITS DERIVATIVES IN THE PREPARATION OF THE PREPARATION
US12/744,349 US8404660B2 (en) 2007-11-25 2008-11-25 Method of obtaining of 4-N-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-N-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
EP08851400.5A EP2225228B1 (en) 2007-11-25 2008-11-25 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
PCT/PL2008/000089 WO2009067035A2 (en) 2007-11-25 2008-11-25 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
PL08851400T PL2225228T3 (pl) 2007-11-25 2008-11-25 Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej
ES08851400.5T ES2610209T3 (es) 2007-11-25 2008-11-25 Procedimiento de obtención de 4-N-furfurilcitosina y/o sus derivados, composición antienvejecimiento y utilización de 4-N-furfurilcitosina y/o sus derivados en la fabricación de una composición antienvejecimiento

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL383867A PL216370B1 (pl) 2007-11-25 2007-11-25 Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej

Publications (2)

Publication Number Publication Date
PL383867A1 true PL383867A1 (pl) 2009-06-08
PL216370B1 PL216370B1 (pl) 2014-03-31

Family

ID=40568369

Family Applications (2)

Application Number Title Priority Date Filing Date
PL383867A PL216370B1 (pl) 2007-11-25 2007-11-25 Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej
PL08851400T PL2225228T3 (pl) 2007-11-25 2008-11-25 Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL08851400T PL2225228T3 (pl) 2007-11-25 2008-11-25 Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej

Country Status (6)

Country Link
US (1) US8404660B2 (pl)
EP (1) EP2225228B1 (pl)
DK (1) DK2225228T3 (pl)
ES (1) ES2610209T3 (pl)
PL (2) PL216370B1 (pl)
WO (1) WO2009067035A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL229581B1 (pl) 2010-03-19 2018-08-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Analog cytozyny i jego zastosowanie w leczeniu chorób związanych z zaburzeniami metylacji DNA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193318B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing new bis- indol derivatives
CA1339503C (en) * 1987-02-26 1997-10-21 Suresh I.S. Rattan Method and composition for ameliorating the adverse effects of aging
US5021422A (en) 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
US5164394A (en) 1989-06-08 1992-11-17 Senetek, Plc Method for treating hyperproliferative skin diseases
JP2000319184A (ja) 1991-05-16 2000-11-21 Senetek Plc 皮膚の美的外観を改善するための方法
US5151425A (en) * 1991-06-20 1992-09-29 Clark Lealand L Method of and composition for treating inflammation and the immunological response thereto
DE4323615A1 (de) 1993-07-12 1995-01-19 Schreiner Edelgard Mittel gegen vorzeitiges Altern der Haut
GB9825687D0 (en) * 1998-11-25 1999-01-20 Link Technologies Ltd Oligonucleotide conjugation
KR100332031B1 (ko) 1999-06-03 2002-04-10 서경배 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물
JP2001031549A (ja) 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
WO2005020885A2 (en) * 2003-05-21 2005-03-10 Isis Pharmaceuticals, Inc. Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
US20090023672A1 (en) * 2005-01-27 2009-01-22 Kurume University Age-2 aptamer

Also Published As

Publication number Publication date
PL2225228T3 (pl) 2017-10-31
US20100317612A1 (en) 2010-12-16
WO2009067035A3 (en) 2009-09-24
WO2009067035A2 (en) 2009-05-28
PL216370B1 (pl) 2014-03-31
US8404660B2 (en) 2013-03-26
EP2225228B1 (en) 2016-10-12
EP2225228A2 (en) 2010-09-08
ES2610209T3 (es) 2017-04-26
DK2225228T3 (en) 2017-01-16

Similar Documents

Publication Publication Date Title
HRP20190408T1 (hr) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
IL220625A (en) Isoindolinone compounds, preparations containing them and their uses
IL211541A0 (en) Co-crystal compositions, methods of producing the same and uses thereof
IL216826A0 (en) Pyridil-triazine derivatives, compositions comprising the same and processes for producing the same
EP2282735A4 (en) COMPOUNDS, COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
EP2340297A4 (en) COMPOSITION, ITS MANUFACTURING METHOD AND USE
GB0717376D0 (en) Composition and manufacture thereof
IL216701A (en) Adhesives, their production and application
PT2451446E (pt) Composição para a produção de comprimidos e processo para a sua produção
EP2133198A4 (en) ARRANGEMENT, METHOD FOR PRODUCING THE ARRANGEMENT, COMPOUND COMPOSITION AND METHOD FOR PRODUCING THE COMPOUND COMPOSITION
PL383867A1 (pl) Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej
ZA200903778B (en) Molded part, and methor for the production of the molded part
EP2117313A4 (en) PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEM
PL382681A1 (pl) Nowa pochodna N-alkilobis(pirydylo)fenotiazyny i sposób wytwarzania pochodnej N-alkilobis(pirydylo)fenotiazyny oraz jej zastosowanie
PL382914A1 (pl) Nowe sililopodstawione 1,2-alkiny oraz sposób otrzymywania sililopodstawionych 1,2-alkinów
GB0709701D0 (en) Composition and process for its production
PL382823A1 (pl) Sposób otrzymywania o-hydroksybenzyloamin
PL382150A1 (pl) Sposób wytwarzania alkilo 3-(acyloamino)-1H- pirazolo-5- karboksylanu
PL383212A1 (pl) Nowa DD-karboksypeptydaza, jej otrzymywanie i zastosowania
PL382315A1 (pl) Sposób wytwarzania S-(-)-6-metoksy-1, 2, 3, 4-tetrahydro-2-naftolu
PL382312A1 (pl) Sposób wytwarzania S-(-)-8-metoksy-1, 2, 3, 4-tetrahydro-2-naftolu
PL382313A1 (pl) Sposób wytwarzania S-(-)-6-chloro-1, 2, 3, 4-tetrahydro-2-naftolu
PL382314A1 (pl) Sposób wytwarzania S-(-)-7-metoksy-1, 2, 3, 4-tetrahydro-2-naftolu
PL382869A1 (pl) Dicyjanoimidki 3-alkoksymetylo-1-metyloimidazoliowe oraz sposób wytwarzania dicyjanoimidków 3-alkoksymetylo-1-metyloimidazoliowych
PL383170A1 (pl) Sposób otrzymywania preparatu wapniowego